Actively Recruiting
CYTALUX for Intraoperative Imaging of Patients With Endometrial Cancer
Led by Abramson Cancer Center at Penn Medicine · Updated on 2025-12-12
10
Participants Needed
2
Research Sites
171 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The research study is being done to assess the safety and ability of an investigational drug called CYTALUX (pafolacianine) and a special camera system for the detection of cancer in patients undergoing surgical resection for endometrial cancer.
CONDITIONS
Official Title
CYTALUX for Intraoperative Imaging of Patients With Endometrial Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed and dated informed consent form
- Age 18 years or older
- Primary diagnosis of endometrial cancer
- Scheduled for surgery to treat endometrial cancer
- Ability to understand study requirements and agree to follow study rules and assessments
- Willingness to stop folate or folic acid supplements at least 48 hours before study drug infusion
You will not qualify if you...
- Pregnancy or positive pregnancy test
- Any medical condition that could risk participant safety as judged by the investigator
- History of severe allergic reactions to products containing indocyanine green
- Allergy to any component of CYTALUX
- Any psychological, family, social, or geographic issues that could interfere with study compliance or follow-up
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Abramson Cancer Center at Penn Medicine
Philadelphia, Pennsylvania, United States, 19104
Actively Recruiting
2
University of Pennsylvania Gynecologic Oncology Department
Philadelphia, Pennsylvania, United States, 19104
Actively Recruiting
Research Team
B
Brianna Aguilar
CONTACT
J
Joseph Agyemang
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here